Searching the Rainforest for Cures

This document discusses the potential and challenges of phytopharmaceuticals derived from tropical rainforests.

Definition: The tropical zone of the Earth stretches from approximately 25 degrees south to 25 degrees north.
Ecological Zones: Different types of ecosystems exist in this area:
- Tropical Rainforest
- Tropical Seasonal Forest
- Desert
- Savanna
- Seasonally Dry Tropical Forest
Land Cover: While tropical rainforests are extremely diverse, most of the tropical area consists of deserts, savannas, or seasonally dry forests.

Tropical rainforests represent the most biodiverse ecosystems on the planet.
Biodiversity in the Amazon Basin: It is estimated that the Amazon Basin alone may harbor up to 50% of all global species and approximately 50,000 species of vascular plants.
Conservation Concerns: Tropical rainforests are rapidly diminishing in size across the globe. Only a small fraction of the flora has been explored for their medicinal properties.

Alkaloid Presence: Up to 45% of tropical rainforest plants contain alkaloids, yet less than 5% of these plants have been researched extensively.

Curare's Usage: Native peoples in the American tropics used poison arrows for hunting for thousands of years.
**Colonial Encounters:
- 1493: Christopher Columbus reportedly had a sailor killed by a poison arrow.
- 1520: Ferdinand Magellan's expedition encountered tribes with poison arrows.
- 1595: Sir Walter Raleigh's exploration of the Orinoco River met tribes that utilized curare, marking the beginning of a lengthy exploration for its source.
Curare's Introduction to Europe: In 1650, Charles La Condamine brought curare to Europe, demonstrating its potency by testing it on chickens, which died within minutes.

Baron von Humboldt's Search: Starting in 1799, he investigated curare for three years.
Identifying Sources: In the 1830s, Robert Schomburgk identified Strychnos toxifera as a source of curare, along with other species, Chondodendron tomentosum and Curarea toxicofera.
Mechanism of Action: Curare (specifically tubocurarine) acts by blocking acetylcholine receptors at the neuromuscular junction, consequently relaxing skeletal muscles, which has surgical applications.

First Successful Use in Anesthesia: On January 23, 1942, Dr. Harold Griffith reported the first successful intravenous use of curare during surgery, providing muscle relaxation without affecting heart rate or blood pressure.
Synthetic Alternatives: Due to overharvesting of curare plants in Peru, synthetic alkaloids like Atracurium and Vecuronium are now used in surgical settings.

Historical Beliefs: Until the late 19th century, malaria was believed to result from bad air near swamps.
Jesuit Contributions: Jesuit missionaries learned of a malaria treatment using quinine bark from South America in the 1630s.
Cinchona Bark: This bark was promoted in Europe for treating fevers by the Jesuits and was dubbed "Jesuits bark."
Notable Cures: The Countess of Cinchon was treated using the bark from the Cinchona plant in 1638, leading to its popularity.
Quinine Sourcing: Quinine is derived from several Cinchona species (C. calisaya, C. officinalis, C. pubescens).
- By 1820, it had been isolated, but demand led to declining wild populations.
Colonial Practices: The British utilized gin and tonic (quinine water) to prevent malaria in their tropical colonies.
WWII Impacts: Supply cut-offs during the Japanese occupation in WWII led to high mortality rates among Allied troops due to malaria.
Synthetic Quinine: Hydroxychloroquine, a synthetic derivative of quinine, was introduced in the 1950s to combat malaria.

Source: Reserpine is derived from the Indian snakeroot (Rauwolfia serpentina).
Historical Uses: It has been used in tropical India for centuries to treat snakebite and mental illness.
Isolation: The active compound, reserpine, was isolated in 1952.
Introduction to the U.S.: In 1950, Robert Wilkins brought reserpine to America for treating high blood pressure. His clinical trials confirmed its efficacy, and it became marketed under the name Raudixin.
Dual Applications: Reserpine was also the first drug tested for psychiatric issues, opening avenues for treating mental health despite not being very successful.
Industry Trends: By the 1960s, reserpine had become a multi-million dollar industry but was later supplanted by newer drugs.

Research on Steroids: The 1940s saw increased study of steroids in medicine.
Rheumatoid Arthritis Relief: Pregnant women experienced symptom relief from rheumatoid arthritis due to increased progesterone levels.
Extraction Innovations: Russell Marker and Percy Julian discovered methods to extract steroid-like compounds from Dioscorea yams, specifically Diosgenin.
Synthesis Growth: Marker established Syntex, producing progesterone at a fraction of prior costs, propelling Syntex's growth substantially.
Cortisone Isolation: In 1942, cortisone was isolated, rapidly gaining demand for its effectiveness in treating arthritis. By 1951, synthetic cortisone became widely available.

Schultes’ Contributions: Richard Schultes collected 24,000 plant species in the Amazon, identifying 2,000 used by local healers, though industry showed limited interest due to patenting issues and costs associated with developing treatments for less prevalent diseases.

**Primary Methods: **
- New use exploration for existing drugs
- Creating analogs and combinations of existing drugs
- Improving delivery methods
- Discovery and testing of new drugs
Material Requirements:
- Bioassays only need small plant amounts, while active compound isolation and further studies may require larger quantities.

Timeline: From plant discovery to drug approval for Taxol took 30 years. Here’s a breakdown:
- 1962: Sample collection for cancer research.
- 1964: Active extracts identified.
- 1971: Chemical structure determined.
- 1992: Approval for clinical use granted, succeeding in treating multiple cancers.

Ancistrocladus korupensis: A potential source of Michellamine B and anti-malarial alkaloids, though endangered.
Artemisia annua: Key source of artemisinin, effective against chloroquine-resistant malaria and potential cancer treatments.
Galanthus caucasicus: Source of galantamine, recently approved for Alzheimer's treatment.
Callistemon citrinus: Source of nitrosinone, treating hereditary tyrosinemia type 1.
Quassia amara: Contains quassin and simalikalactone D, both showing promise as new antimalarial drugs.